PAX5 (Paired box protein Pax-5) variants and mutations
PAX5 (also known as Paired box protein Pax-5) is a human protein-coding gene encoding a paired box protein Pax-5 protein. It establishes and maintains B-cell identity by activating B-lineage genes and repressing alternative developmental programs. Somatic loss, mutation, or rearrangement is common in B-cell acute lymphoblastic leukemia, while germline variants can confer leukemia susceptibility and immunodeficiency. This analysis covers 1,087 PAX5 variants and mutations. Of these, 60% have computational variant effect predictions. Disease context includes leukemia, acute lymphoblastic, susceptibility to, 3, acute lymphoblastic leukemia, and neurodegenerative disease. Example PAX5 variants include D2E, D2H, and D2N.
Variant analysis overview
- Gene: PAX5
- Protein: Paired box protein Pax-5
- UniProt accession: Q02548
- Organism: Homo sapiens
- Variants analyzed: 1087
- Variant scope: all variants
- Completed: 2026-08-19
Variant and mutation evidence
- Variant composition: 920 unspecified-consequence records; 1 stop retained variant; 4 stop lost; 31 synonymous variants; 110 missense variants; 12 frameshift variants; 4 stop-gained variants; 3 in-frame deletions; 1 splice-region variants; 1 substitution
- Prediction scores: 654 variants have prediction scores (60% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: leukemia, acute lymphoblastic, susceptibility to, 3, acute lymphoblastic leukemia, neurodegenerative disease, neurodevelopmental disorder, major depressive disorder, hereditary disease, prostate adenocarcinoma, insomnia, bipolar disorder, B-cell acute lymphoblastic leukemia, lymphoid neoplasm, lung carcinoma.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable PAX5 variants
Examples include D2E, D2H, D2N, D2Y, L3V, E4K, K5R, K5T. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- D2E (p.Asp2Glu), rs139701864, ClinGen CA161358, cosmic curated COSV10744, ClinVar RCV000121764, REVEL 0.28, MetaLR 0.77, Benign/Likely benign, not specified; not provided
- D2H (p.Asp2His), cosmic curated COSV10527, NCI-TCGA Cosmic COSV6391, 1000Genomes rs1841280101, TOPMed rs1841280101, REVEL 0.46, MetaLR 0.91, Variant assessed as somatic; moderate impact.
- D2N (p.Asp2Asn), cosmic curated COSV63912, 1000Genomes rs1841280101, TOPMed rs1841280101, gnomAD rs1841280101, REVEL 0.39, MetaLR 0.88
- D2Y (p.Asp2Tyr), cosmic curated COSV10467, 1000Genomes rs1841280101, TOPMed rs1841280101, gnomAD rs1841280101, REVEL 0.54, MetaLR 0.91
- L3V (p.Leu3Val), 1000Genomes rs1841279599, Uncertain significance, Inborn genetic diseases
- E4K (p.Glu4Lys), gnomAD rs1191743397, REVEL 0.40, MetaLR 0.86
- K5R (p.Lys5Arg), gnomAD rs1430740493, REVEL 0.32, AlphaMissense 0.17
- K5T (p.Lys5Thr), cosmic curated COSV63909, gnomAD rs1430740493
- Y7C (p.Tyr7Cys), cosmic curated COSV10744, NCI-TCGA TCGA novel, REVEL 0.53, AlphaMissense 0.08, Variant assessed as somatic; moderate impact.
- Y7H (p.Tyr7His), cosmic curated COSV63910, gnomAD rs1193338656, REVEL 0.43, MetaLR 0.87
- Y7S (p.Tyr7Ser), Ensembl rs1841278354, REVEL 0.33, AlphaMissense 0.06
- P8A (p.Pro8Ala), cosmic curated COSV10527, 1000Genomes rs1466879183, TOPMed rs1466879183, gnomAD rs1466879183, REVEL 0.27, MetaLR 0.79, Uncertain significance
- P8L (p.Pro8Leu), cosmic curated COSV63905, TOPMed rs1401484095, REVEL 0.34, MetaLR 0.84, Uncertain significance, Inborn genetic diseases
- P8S (p.Pro8Ser), rs1466879183, ClinGen CA373486907, cosmic curated COSV10527, ClinVar RCV002254870, REVEL 0.31, MetaLR 0.82, Uncertain significance, Leukemia, acute lymphoblastic, susceptibility to, 3; not provided; Inborn geneti
- P10A (p.Pro10Ala), gnomAD rs1254538004, REVEL 0.36, MetaLR 0.77
- P10L (p.Pro10Leu), cosmic curated COSV63910, TOPMed rs921644175, gnomAD rs921644175, REVEL 0.34, AlphaMissense 0.10, Uncertain significance, not provided
- P10S (p.Pro10Ser), gnomAD rs1254538004
- R11P (p.Arg11Pro), ExAC rs759944754
- R11Q (p.Arg11Gln), ExAC rs759944754, REVEL 0.46, MetaLR 0.91, Uncertain significance, Inborn genetic diseases
- R11W (p.Arg11Trp), cosmic curated COSV63908, Ensembl rs2132593071
- T12N (p.Thr12Asn), TOPMed rs1841276454, REVEL 0.38, MetaLR 0.74, Uncertain significance, Inborn genetic diseases
- S13G (p.Ser13Gly), rs1338245101, gnomAD rs1338245101, REVEL 0.24, AlphaMissense 0.06, Variant assessed as somatic; moderate impact.
- S13I (p.Ser13Ile), gnomAD rs1249107807, REVEL 0.28, MetaLR 0.90
- S13N (p.Ser13Asn), cosmic curated COSV63914, gnomAD rs1249107807, REVEL 0.23, MetaLR 0.83
- S13T (p.Ser13Thr), NCI-TCGA Cosmic COSV6391, gnomAD rs1249107807, REVEL 0.25, MetaLR 0.81, Uncertain significance, Inborn genetic diseases
- R14G (p.Arg14Gly), ExAC rs763290609, gnomAD rs763290609, REVEL 0.60, AlphaMissense 0.06
- R14K (p.Arg14Lys), cosmic curated COSV10818, TOPMed rs1841275340
- R14S (p.Arg14Ser), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63906, REVEL 0.53, MetaLR 0.83, Variant assessed as somatic; moderate impact.
- G16R (p.Gly16Arg), NCI-TCGA Cosmic COSV6391, cosmic curated COSV63914, cosmic curated COSV63911, REVEL 0.85, MetaLR 0.98, Variant assessed as somatic; moderate impact.
- G18A (p.Gly18Ala), Ensembl rs2132503794
- G19* (p.Gly19Ter), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63905, Variant assessed as somatic; high impact.
- G19R (p.Gly19Arg), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63905, Variant assessed as somatic; moderate impact.
- V20L (p.Val20Leu), Ensembl rs2132503767
- N21D (p.Asn21Asp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- N21H (p.Asn21His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- Q22K (p.Gln22Lys), rs2494557134, ClinGen CA373488505, ClinVar RCV002896757, Uncertain significance, Inborn genetic diseases
- L23F (p.Leu23Phe), Ensembl rs2132503735
- L23P (p.Leu23Pro), NCI-TCGA Cosmic COSV6390, NCI-TCGA Cosmic COSV6391, cosmic curated COSV63910, Variant assessed as somatic; moderate impact.
- G24E (p.Gly24Glu), rs936072547, TOPMed rs936072547, gnomAD rs936072547, REVEL 0.95, MetaLR 0.99, Variant assessed as somatic; moderate impact.
- G24R (p.Gly24Arg), rs868494257, cosmic curated COSV10527, UniProt VAR 070672, Ensembl rs868494257, AlphaMissense 1.00, MetaLR 0.99
- G24V (p.Gly24Val), TOPMed rs936072547, gnomAD rs936072547, REVEL 0.97, MetaLR 0.99
- G24W (p.Gly24Trp), NCI-TCGA Cosmic COSV6390, NCI-TCGA Cosmic COSV6391, Ensembl rs868494257, Variant assessed as somatic; moderate impact.
- G25W (p.Gly25Trp), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- V26D (p.Val26Asp), Ensembl rs926053251, REVEL 0.93, MetaLR 0.99, Likely pathogenic
- V26F (p.Val26Phe), NCI-TCGA Cosmic COSV6390, NCI-TCGA TCGA novel, cosmic curated COSV63906, Ensembl rs2132503670, REVEL 0.91, AlphaMissense 1.00, Variant assessed as somatic; high impact.
- V26G (p.Val26Gly), rs926053251, ClinGen CA193163991, NCI-TCGA Cosmic COSV6390, cosmic curated COSV63904, REVEL 0.94, MetaLR 0.99, Likely pathogenic, Acute lymphoid leukemia
- V26I (p.Val26Ile), Ensembl rs2132503670
- F27L (p.Phe27Leu), ExAC rs776721598, TOPMed rs776721598, gnomAD rs776721598
- G30R (p.Gly30Arg), cosmic curated COSV10943, NCI-TCGA Cosmic COSV6391, Variant assessed as somatic; moderate impact.
- R31Q (p.Arg31Gln), rs1839782073, ClinGen CA373488446, NCI-TCGA Cosmic COSV6390, cosmic curated COSV63904, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, not provided
- R31W (p.Arg31Trp), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63905, ExAC rs764109577, gnomAD rs764109577, REVEL 0.97, MetaLR 0.99, Uncertain significance, not provided
- P32S (p.Pro32Ser), cosmic curated COSV10591, NCI-TCGA TCGA novel, Ensembl rs2132503576, Variant assessed as somatic; moderate impact.
- L33F (p.Leu33Phe), cosmic curated COSV10943, Ensembl rs2132503544
- L33P (p.Leu33Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P34L (p.Pro34Leu), rs1839781585, ClinGen CA373488426, cosmic curated COSV63907, ClinVar RCV003664225, REVEL 0.95, AlphaMissense 1.00, Uncertain significance, Leukemia, acute lymphoblastic, susceptibility to, 3; not provided
- P34Q (p.Pro34Gln), rs1839781585, cosmic curated COSV63912, UniProt VAR 070674, TOPMed rs1839781585, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance
- D35Y (p.Asp35Tyr), cosmic curated COSV10527, Ensembl rs2132503478
- V36A (p.Val36Ala), cosmic curated COSV63908, 1000Genomes rs564013593, ExAC rs564013593, gnomAD rs564013593, REVEL 0.67, MetaLR 0.95, Uncertain significance, not provided
- V36I (p.Val36Ile), ExAC rs570062385, gnomAD rs570062385, REVEL 0.50, AlphaMissense 0.92, Uncertain significance, Inborn genetic diseases
- R38C (p.Arg38Cys), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63908, TOPMed rs1839780542, REVEL 0.95, MetaLR 1.00, Variant assessed as somatic; moderate impact.
- R38H (p.Arg38His), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63906, Ensembl rs2132503415, REVEL 0.97, MetaLR 1.00, Variant assessed as somatic; moderate impact.
- R38P (p.Arg38Pro), NCI-TCGA Cosmic COSV6390, Ensembl rs2132503415, Variant assessed as somatic; moderate impact.
- Q39* (p.Gln39Ter), Ensembl rs2132503402
- R40K (p.Arg40Lys), Ensembl rs999324823, Uncertain significance, Inborn genetic diseases
- R40M (p.Arg40Met), Ensembl rs999324823
- I41T (p.Ile41Thr), NCI-TCGA Cosmic COSV6391, cosmic curated COSV63912, Variant assessed as somatic; moderate impact.
- E43G (p.Glu43Gly), TOPMed rs1588249546
- E43V (p.Glu43Val), TOPMed rs1588249546
- A45V (p.Ala45Val), Ensembl rs2132503342, Uncertain significance, Inborn genetic diseases
- H46Y (p.His46Tyr), TOPMed rs1288960060, REVEL 0.87, MetaLR 0.98
- Q47R (p.Gln47Arg), ExAC rs774147019, gnomAD rs774147019, REVEL 0.73, AlphaMissense 0.98
- G48C (p.Gly48Cys), NCI-TCGA TCGA novel, REVEL 0.97, MetaLR 0.99, Variant assessed as somatic; moderate impact.
- G48D (p.Gly48Asp), Ensembl rs2132503279
- G48S (p.Gly48Ser), ExAC rs770569112, gnomAD rs770569112, REVEL 0.96, MetaLR 0.99
- G48V (p.Gly48Val), Ensembl rs2132503279
- R50G (p.Arg50Gly), ExAC rs748927107, TOPMed rs748927107, gnomAD rs748927107
- R50S (p.Arg50Ser), ExAC rs777522556, TOPMed rs777522556, gnomAD rs777522556, Likely benign
- P51H (p.Pro51His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- C52R (p.Cys52Arg), Ensembl rs2132503200
- D53H (p.Asp53His), rs1337956293, ClinGen CA373488306, ClinVar RCV001580197, TOPMed rs1337956293, REVEL 0.94, MetaLR 0.98, Pathogenic, Neurodevelopmental disorder
- D53N (p.Asp53Asn), rs1337956293, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, TOPMed rs1337956293, REVEL 0.88, MetaLR 0.99, Uncertain significance, Inborn genetic diseases
- D53V (p.Asp53Val), rs2132503160, cosmic curated COSV63905, UniProt VAR 070675, Ensembl rs2132503160, AlphaMissense 1.00, MetaLR 0.97
- R56G (p.Arg56Gly), NCI-TCGA TCGA novel, Ensembl rs2132503115, Variant assessed as somatic; moderate impact.
- Q57* (p.Gln57Ter), gnomAD rs1406498440
- Q57K (p.Gln57Lys), gnomAD rs1406498440, REVEL 0.87, MetaLR 0.98
- L58P (p.Leu58Pro), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L58V (p.Leu58Val), cosmic curated COSV63907, Ensembl rs2132503069
- R59G (p.Arg59Gly), UniProt VAR 070676
- R59Q (p.Arg59Gln), Ensembl rs2132503032, REVEL 0.84, MetaLR 0.98
- R59W (p.Arg59Trp), NCI-TCGA Cosmic COSV6390, NCI-TCGA Cosmic COSV6391, cosmic curated COSV63914, Ensembl rs2132503046, Variant assessed as somatic; moderate impact.
- V60F (p.Val60Phe), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, NCI-TCGA Cosmic COSV6391, Variant assessed as somatic; moderate impact.
- V60G (p.Val60Gly), Ensembl rs1588249260
- S61N (p.Ser61Asn), Ensembl rs2132502998
- H62N (p.His62Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- H62Q (p.His62Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G63D (p.Gly63Asp), Ensembl rs2132502973
- C64Y (p.Cys64Tyr), Ensembl rs2132502964
- V65D (p.Val65Asp), Ensembl rs2132502951
- S66N (p.Ser66Asn), rs2132502937, ClinGen CA373488215, NCI-TCGA Cosmic COSV9905, ClinVar RCV003444137, AlphaMissense 1.00, MetaLR 0.99, Uncertain significance, Acute lymphoid leukemia
- S66R (p.Ser66Arg), Ensembl rs2132502922
- L69I (p.Leu69Ile), cosmic curated COSV10818, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L69P (p.Leu69Pro), Ensembl rs2132502907
- G70A (p.Gly70Ala), Ensembl rs1839776228, Uncertain significance, Inborn genetic diseases
- G70S (p.Gly70Ser), Ensembl rs2132502875, REVEL 0.82, MetaLR 0.96, Uncertain significance, Inborn genetic diseases
- R71M (p.Arg71Met), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Variant assessed as somatic; moderate impact.
- Y72C (p.Tyr72Cys), NCI-TCGA Cosmic COSV6390, cosmic curated COSV63905, Variant assessed as somatic; moderate impact.
- Y72D (p.Tyr72Asp), Ensembl rs1588233482
- Y72H (p.Tyr72His), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- E74Q (p.Glu74Gln), gnomAD rs1839287837, REVEL 0.92, MetaLR 0.99
- T75K (p.Thr75Lys), NCI-TCGA Cosmic COSV6390, NCI-TCGA Cosmic COSV6391, Variant assessed as somatic; high impact.
- T75R (p.Thr75Arg), UniProt VAR 070678
- G76* (p.Gly76Ter), Ensembl rs2132472697
- G76V (p.Gly76Val), NCI-TCGA Cosmic COSV6390, Variant assessed as somatic; moderate impact.
- S77N (p.Ser77Asn), NCI-TCGA TCGA novel, Ensembl rs2132472667, Variant assessed as somatic; moderate impact.
- K79E (p.Lys79Glu), TOPMed rs1839286871
- P80R (p.Pro80Arg), rs2494512979, ClinGen CA373488100, ClinVar RCV000766127, NCI-TCGA Cosmic COSV6390, Likely pathogenic
- G81A (p.Gly81Ala), Ensembl rs2132472571
- G81E (p.Gly81Glu), Ensembl rs2132472571
- G81R (p.Gly81Arg), Ensembl rs2132472595
- G81V (p.Gly81Val), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Ensembl rs2132472571, Variant assessed as somatic; moderate impact.
- G81W (p.Gly81Trp), Ensembl rs2132472595, REVEL 0.93, MetaLR 0.99
- V82I (p.Val82Ile), rs587778589, ClinGen CA161363, ClinVar RCV000121766, ClinVar RCV003688827, REVEL 0.67, AlphaMissense 1.00, Benign, not specified; not provided
- V82L (p.Val82Leu), ExAC rs587778589, TOPMed rs587778589, gnomAD rs587778589, Benign
- G84* (p.Gly84Ter), Ensembl rs2132472500
- G84A (p.Gly84Ala), Ensembl rs2132472473
- G84E (p.Gly84Glu), Ensembl rs2132472473
- G84V (p.Gly84Val), Ensembl rs2132472473
- G85* (p.Gly85Ter), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, NCI-TCGA Cosmic COSV6391, Ensembl rs2132472428, Likely pathogenic
- G85A (p.Gly85Ala), gnomAD rs1254060202
- G85E (p.Gly85Glu), cosmic curated COSV10467, gnomAD rs1254060202
- G85R (p.Gly85Arg), rs2132472428, ClinGen CA373488072, NCI-TCGA Cosmic COSV1008, NCI-TCGA Cosmic COSV6391, AlphaMissense 1.00, MetaLR 0.99, Conflicting interpretations, not provided; Leukemia, acute lymphoblastic, susceptibility to, 3
- G85V (p.Gly85Val), rs1254060202, NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, gnomAD rs1254060202, REVEL 0.98, AlphaMissense 1.00, Variant assessed as somatic; moderate impact.
- S86C (p.Ser86Cys), Ensembl rs2132472356
- S86P (p.Ser86Pro), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Variant assessed as somatic; moderate impact.
- S86T (p.Ser86Thr), Ensembl rs2132472365
- K87N (p.Lys87Asn), Ensembl rs2132472333
- P88A (p.Pro88Ala), Ensembl rs2132472323
- K89L (p.Lys89Leu), Ensembl rs2132472283
- K89R (p.Lys89Arg), Ensembl rs2132472270
- V90G (p.Val90Gly), Ensembl rs2132472242
- V90I (p.Val90Ile), Ensembl rs2132472254
- V90L (p.Val90Leu), Ensembl rs2132472254
- A91D (p.Ala91Asp), Ensembl rs2132472178
- A91P (p.Ala91Pro), TOPMed rs1223489007, gnomAD rs1223489007
- A91S (p.Ala91Ser), TOPMed rs1223489007, gnomAD rs1223489007
- A91T (p.Ala91Thr), rs1223489007, NCI-TCGA Cosmic COSV6391, cosmic curated COSV63910, TOPMed rs1223489007, REVEL 0.68, AlphaMissense 0.96, Variant assessed as somatic; moderate impact.
- A91V (p.Ala91Val), Ensembl rs2132472178
- T92I (p.Thr92Ile), TOPMed rs1839283277, REVEL 0.81, AlphaMissense 1.00, Uncertain significance, Inborn genetic diseases
- T92K (p.Thr92Lys), NCI-TCGA TCGA novel, Uncertain significance, Inborn genetic diseases
- T92R (p.Thr92Arg), TOPMed rs1839283277
- P93A (p.Pro93Ala), Ensembl rs2132472130
- P93H (p.Pro93His), Ensembl rs2132472118
- P93L (p.Pro93Leu), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Uncertain significance, Inborn genetic diseases
- P93S (p.Pro93Ser), cosmic curated COSV10527, Ensembl rs2132472130, REVEL 0.76, MetaLR 0.99, Uncertain significance, Inborn genetic diseases
- K94* (p.Lys94Ter), Ensembl rs2132472090
- K94N (p.Lys94Asn), Ensembl rs2132472073
- K94Q (p.Lys94Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- V95E (p.Val95Glu), Ensembl rs2132472040
- V95G (p.Val95Gly), Ensembl rs2132472040
- V95L (p.Val95Leu), Ensembl rs2132472060
- V96A (p.Val96Ala), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Variant assessed as somatic; moderate impact.
- V96L (p.Val96Leu), Ensembl rs2132472001
- V96M (p.Val96Met), Ensembl rs2132472001
- E97* (p.Glu97Ter), Ensembl rs2132471969
- E97D (p.Glu97Asp), NCI-TCGA Cosmic COSV6391, cosmic curated COSV63912, Uncertain significance, Inborn genetic diseases
- E97Q (p.Glu97Gln), Ensembl rs2132471969, Uncertain significance, Inborn genetic diseases
- K98I (p.Lys98Ile), NCI-TCGA Cosmic COSV1008, cosmic curated COSV10081, Variant assessed as somatic; moderate impact.
- K98N (p.Lys98Asn), cosmic curated COSV10081, gnomAD rs1212636536, REVEL 0.81, AlphaMissense 0.10, Uncertain significance, Inborn genetic diseases
- I99F (p.Ile99Phe), cosmic curated COSV63915, Ensembl rs1564078870
- I99L (p.Ile99Leu), Ensembl rs1564078870, REVEL 0.89, AlphaMissense 0.80
- I99M (p.Ile99Met), TOPMed rs1259063388, gnomAD rs1259063388
- I99N (p.Ile99Asn), Ensembl rs2132471928, NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- A100D (p.Ala100Asp), cosmic curated COSV10081, Ensembl rs2132471861
- A100G (p.Ala100Gly), Ensembl rs2132471861
- A100P (p.Ala100Pro), TOPMed rs1313118042, gnomAD rs1313118042
- A100S (p.Ala100Ser), TOPMed rs1313118042, gnomAD rs1313118042, REVEL 0.61, MetaLR 0.96
- A100T (p.Ala100Thr), rs1313118042, NCI-TCGA Cosmic COSV6390, cosmic curated COSV63905, TOPMed rs1313118042, REVEL 0.58, MetaLR 0.96, Variant assessed as somatic; moderate impact.
- E101K (p.Glu101Lys), Ensembl rs2132471832
- E101Q (p.Glu101Gln), Ensembl rs2132471832
- Y102N (p.Tyr102Asn), Ensembl rs2132471819
Public PAX5 analysis runs
- PAX5 analysis run — PAX5 (1,087 variants) — completed 2026-08-19